Crohn’s disease: a clinical update
暂无分享,去创建一个
Hanan Khalil | H. Khalil | Francis Ha | F. Ha
[1] Philippe Seksik,et al. Epidemiology and natural history of inflammatory bowel diseases. , 2011, Gastroenterology.
[2] D. Rex. Methotrexate for Maintenance of Remission in Crohn's Disease , 2000 .
[3] M. V. van Oijen,et al. Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-analysis of Population-based Cohort Studies , 2013, Inflammatory bowel diseases.
[4] P. Siersema,et al. Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis. , 2014, Journal of Crohn's & colitis.
[5] A. Zinsmeister,et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. , 2010, Gastroenterology.
[6] P. Moayyedi,et al. Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis , 2011, The American Journal of Gastroenterology.
[7] J. Lennard-jones,et al. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. , 1997, European journal of gastroenterology & hepatology.
[8] B. Calkins. A meta-analysis of the role of smoking in inflammatory bowel disease , 1989, Digestive diseases and sciences.
[9] Sanjay V. Patel,et al. Laparoscopic surgery for Crohn’s disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery , 2013, BMC Surgery.
[10] Stefan Schreiber,et al. Diagnostics of inflammatory bowel disease. , 2007, Gastroenterology.
[11] T. Matsui,et al. Crohn's disease in Japan , 2000, Diseases of the colon and rectum.
[12] A. Zinsmeister,et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. , 2002, Gastroenterology.
[13] K. Abrams,et al. Meta‐analysis: mortality in Crohn’s disease , 2007, Alimentary pharmacology & therapeutics.
[14] M. Vatn,et al. Clustering in time of familial IBD separates ulcerative colitis from Crohn's disease , 2009, Inflammatory bowel diseases.
[15] S. Lourenço,et al. Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.
[16] Kristin Stephens,et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. , 2013, The New England journal of medicine.
[17] Alan Barkun,et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. , 2015, Gastrointestinal endoscopy.
[18] M. Picco. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease , 2011 .
[19] R. Gearry,et al. High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study , 2006, Inflammatory bowel diseases.
[20] A. Clegg,et al. A case–control study of childhood environmental risk factors for the development of inflammatory bowel disease , 2002, European journal of gastroenterology & hepatology.
[21] M. Muñoz-Navas,et al. Capsule endoscopy. , 2009, World journal of gastroenterology.
[22] Conor P. Delaney,et al. Advantages of Laparoscopic Resection for Ileocecal Crohn’s Disease , 2002, Diseases of the colon and rectum.
[23] P. Tekkis,et al. The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis , 2008, The American Journal of Gastroenterology.
[24] R. McLeod,et al. Position Statement on the Diagnosis and Management of olorectal Neoplasia in Inflammatory Bowel Disease , 2022 .
[25] P. Siersema,et al. Sa1167 Determinants of Health-Related Quality of Life in Crohn's Disease: A Systematic Review and Meta-Analysis , 2013 .
[26] Tetsuya Nakamura,et al. Capsule endoscopy: past, present, and future , 2008, Journal of Gastroenterology.
[27] M. Spehlmann,et al. Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study , 2008, Inflammatory bowel diseases.
[28] K. Beusterien,et al. The Burden of Inflammatory Bowel Disease: A Patient-reported Qualitative Analysis and Development of a Conceptual Model , 2014, Inflammatory bowel diseases.
[29] J. McDonnell,et al. Important cutaneous manifestations of inflammatory bowel disease , 2005, Postgraduate Medical Journal.
[30] G. Greenberg,et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. , 2012, The New England journal of medicine.
[31] S. Ng,et al. Role of genetic and environmental factors in British twins with inflammatory bowel disease , 2012, Inflammatory bowel diseases.
[32] S. Ng,et al. Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review , 2012, Inflammatory bowel diseases.
[33] J. Church,et al. Quality of life improves within 30 days of surgery for Crohn's disease. , 2003, Journal of the American College of Surgeons.
[34] W. Sandborn,et al. Crohn's disease , 2012, The Lancet.
[35] R. Balfour Sartor,et al. Microbial host interactions in IBD: Implications for pathogenesis and therapy , 2007, Current gastroenterology reports.
[36] B. Cagir,et al. Malignant Transformation in Perianal Fistulas of Crohn’s Disease: a Systematic Review of Literature , 2009, Journal of Gastrointestinal Surgery.
[37] D. McKay,et al. Laparoscopic versus Open surgery for small bowel Crohn's disease. , 2011, The Cochrane database of systematic reviews.
[38] A. Buda,et al. Intestinal Surgery for Crohn’s Disease: Predictors of Recovery, Quality of Life, and Costs , 2009, Journal of Gastrointestinal Surgery.
[39] J. Gisbert,et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease , 2011, Alimentary pharmacology & therapeutics.
[40] S. Travis,et al. Introducing vedolizumab to clinical practice: who, when, and how? , 2015, Journal of Crohn's & colitis.
[41] W. Sandborn,et al. An Update on the Epidemiology of Inflammatory Bowel Disease in Asia , 2008, The American Journal of Gastroenterology.
[42] X. Bossuyt. Serologic markers in inflammatory bowel disease. , 2006, Clinical chemistry.
[43] Mieke Koehoorn,et al. The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study , 2006, The American Journal of Gastroenterology.
[44] J. Barrett,et al. New IBD genetics: common pathways with other diseases , 2011, Gut.
[45] J. Halfvarson,et al. Environmental factors in inflammatory bowel disease: A co‐twin control study of a Swedish‐Danish twin population , 2006, Inflammatory bowel diseases.
[46] H. Ahn,et al. Incidence and Natural Course of Inflammatory Bowel Disease in Korea, 2006–2012: A Nationwide Population-based Study , 2015, Inflammatory bowel diseases.
[47] Z. Fireman,et al. Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970-1980. , 1989, The American journal of gastroenterology.
[48] R. Cohen,et al. The cost of hospitalization in Crohn's disease , 2000, American Journal of Gastroenterology.
[49] O Bernell,et al. Risk factors for surgery and postoperative recurrence in Crohn's disease. , 2000, Annals of surgery.
[50] H. El‐Serag,et al. Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature , 2011, The American Journal of Gastroenterology.
[51] Nancy Xiaonan Yu,et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study , 2001, American Journal of Gastroenterology.
[52] A. Cheifetz,et al. Capsule endoscopy for small-bowel evaluation in Crohn's disease. , 2011, Gastrointestinal endoscopy.
[53] C. Bernstein,et al. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. , 2005, Gastroenterology.
[54] M. Silverberg,et al. Future directions in inflammatory bowel disease management. , 2014, Journal of Crohn's & colitis.
[55] B. Sands. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. , 2004, Gastroenterology.
[56] A. Otley,et al. Budesonide for induction of remission in Crohn's disease. , 2005, The Cochrane database of systematic reviews.
[57] P. Rutgeerts,et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.
[58] G. Kaplan,et al. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis. , 2015, Gastroenterology.
[59] A. Tjønneland,et al. Serological markers predict inflammatory bowel disease years before the diagnosis , 2012, Gut.
[60] G. Rogler,et al. Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort , 2011, The American Journal of Gastroenterology.
[61] M. Picco. Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease , 2009 .
[62] C. O'Morain,et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. , 2010, Journal of Crohn's & colitis.
[63] R. Trivedi,et al. Evaluation of chronic diarrhea. , 2011, American family physician.
[64] J. González,et al. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project , 2012, Gut.
[65] R. Steele,et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) , 2010, Gut.
[66] P. Seksik,et al. Predictors of Crohn's disease. , 2006, Gastroenterology.
[67] I. Leodolter. [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.
[68] A. Akobeng,et al. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease. , 2005, The Cochrane database of systematic reviews.
[69] A. Hara,et al. Capsule Endoscopy Has a Significantly Higher Diagnostic Yield in Patients With Suspected and Established Small-Bowel Crohn's Disease: A Meta-Analysis , 2010, The American Journal of Gastroenterology.
[70] K. Motil,et al. bowel disease , 2022 .
[71] L. Peyrin-Biroulet,et al. Review article: the natural history of postoperative Crohn's disease recurrence , 2012, Alimentary pharmacology & therapeutics.
[72] J. Macdonald,et al. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. , 2013, The Cochrane database of systematic reviews.
[73] Z. Zeng,et al. Systematic review with meta‐analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease , 2014, Alimentary pharmacology & therapeutics.